The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients / Piccaluga, Pp; Malagola, M; Amabile, M; Rondoni, M; Paolini, S; Pane, Fabrizio; Russo, D; Visani, G; Baccarani, M; Martinelli, G.. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 89:10(2004), pp. 1269-1271.
The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients.
PANE, FABRIZIO;
2004
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
